The Potential Role of Gut Bacteriome Dysbiosis as a Leading Cause of Periprosthetic Infection: A Comprehensive Literature Review

(1) Background: Periprosthetic joint infections (PJIs) represent a small yet important risk when undertaking a joint arthroplasty; they occur in approximately 1–2% of treatments. These infections create a medical and financial burden for patients and healthcare systems. Despite the introduction of recognized best clinical practices during arthroplasty operations, it is not yet possible to further reduce the risk of infection after surgery. The purpose of this review is to raise awareness of the potential role of gut dysbiosis in the development of PJIs and to highlight the potential of the gut bacteriome as a possible target for preventing them. (2) Methods: We compiled all the available data from five databases, examining the effects of gut dysbiosis in human and murine studies, following PRISMA guidelines, for a total of five reviewed studies. (3) Results: One human and one murine study found the Trojan horse theory applicable. Additionally, inflammatory bowel diseases, gut permeability, and oral antibiotic ingestion all appeared to play a role in promoting gut dysbiosis to cause PJIs, according to the other three studies. (4) Conclusions: Gut dysbiosis is linked to an increased risk of PJI.

[1]  U. Schmitz,et al.  Single-cell and long-read sequencing to enhance modelling of splicing and cell-fate determination. , 2023, Computational and structural biotechnology journal.

[2]  A. Di Martino,et al.  Which Patients with Chronic Periprosthetic Joint Infection Are Less Suitable to Successful Two Stage Exchange Arthroplasty Surgery? A Retrospective Clinical Trial , 2023, Clinics and practice.

[3]  Hytham S. Salem,et al.  Inflammatory bowel disease is associated with increased complications after total knee arthroplasty. , 2022, The Knee.

[4]  J. Parvizi,et al.  Gut permeability may be associated with periprosthetic joint infection after total hip and knee arthroplasty , 2022, Scientific Reports.

[5]  A. Yadegar,et al.  Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp. , 2022, Frontiers in Medicine.

[6]  J. Parvizi,et al.  Periprosthetic Joint Infection and the Trojan Horse Theory: Examining the Role of Gut Dysbiosis and Epithelial Integrity. , 2022, The Journal of arthroplasty.

[7]  Xue Liang,et al.  Single‐cell RNA sequencing technologies and applications: A brief overview , 2022, Clinical and translational medicine.

[8]  S. Danese,et al.  Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease , 2021, Frontiers in Physiology.

[9]  Lanjuan Li,et al.  Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease , 2021, Frontiers in Cellular and Infection Microbiology.

[10]  J. Parvizi,et al.  Inflammatory Bowel Diseases Increase the Risk of Periprosthetic Joint Infection , 2021, The Journal of bone and joint surgery. American volume.

[11]  N. Harlianto,et al.  Reinfection rates after one- and two-stage revision surgery for hip and knee arthroplasty: a systematic review and meta-analysis , 2021, Archives of Orthopaedic and Trauma Surgery.

[12]  T. Gosiewski,et al.  Association of Fungi and Archaea of the Gut Microbiota with Crohn’s Disease in Pediatric Patients—Pilot Study , 2021, Pathogens.

[13]  Robin Patel,et al.  Microbiology of hip and knee periprosthetic joint infections: A database study. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  R. Hoffmann,et al.  Future burden of primary and revision hip arthroplasty in Germany: a socio-economic challenge , 2021, Archives of Orthopaedic and Trauma Surgery.

[15]  E. Vasarhelyi,et al.  The economic impact of periprosthetic infection in total knee arthroplasty , 2021, Canadian journal of surgery. Journal canadien de chirurgie.

[16]  J. C. Pérez.  Fungi of the human gut microbiota: Roles and significance. , 2021, International journal of medical microbiology : IJMM.

[17]  M. Cross,et al.  Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States. , 2020, The Journal of arthroplasty.

[18]  A. Ferretti,et al.  Prevention of Periprosthetic Joint Infection (PJI): A Clinical Practice Protocol in High-Risk Patients , 2020, Tropical medicine and infectious disease.

[19]  C. Hernandez.  Musculoskeletal microbiology: The utility of the microbiome in orthopedics , 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[20]  E. Elinav,et al.  Phages and their potential to modulate the microbiome and immunity , 2020, Cellular & Molecular Immunology.

[21]  Trevor C. Charles,et al.  Microbiome definition re-visited: old concepts and new challenges , 2020, Microbiome.

[22]  Hanqiang Jin,et al.  Intestinal methicillin-resistant Staphylococcus aureus causes prosthetic infection via ‘Trojan Horse’ mechanism: Evidence from a rat model , 2020, Bone & joint research.

[23]  P. Kovacs,et al.  Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders? , 2020, Nutrients.

[24]  Xu Yang,et al.  Disruption of the Gut Microbiome Increases the Risk of Periprosthetic Joint Infection in Mice. , 2019, Clinical orthopaedics and related research.

[25]  C. Perka,et al.  Origin and characteristics of haematogenous periprosthetic joint infection. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  O. Borens,et al.  Periprosthetic joint infection: current concepts and outlook , 2019, EFORT open reviews.

[27]  M. Camilleri.  Leaky gut: mechanisms, measurement and clinical implications in humans , 2019, Gut.

[28]  Á. Soriano,et al.  The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms , 2019, Journal of clinical medicine.

[29]  H. Lai,et al.  Probiotics, prebiotics and amelioration of diseases , 2019, Journal of Biomedical Science.

[30]  J. Ferguson,et al.  Development of the Gut Microbiome in Children, and Lifetime Implications for Obesity and Cardiometabolic Disease , 2018, Children.

[31]  A. Leithner,et al.  Trends and Economic Impact of Hip and Knee Arthroplasty in Central Europe: Findings from the Austrian National Database , 2018, Scientific Reports.

[32]  R. Eri,et al.  Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective , 2018, BioMed research international.

[33]  K. Jadallah,et al.  Protozoan parasites in irritable bowel syndrome: A case-control study , 2017, World journal of gastrointestinal pharmacology and therapeutics.

[34]  A. Duffy,et al.  Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes. , 2017, The Journal of nutrition.

[35]  T. Seyler,et al.  Specific Infectious Organisms Associated With Poor Outcomes in Treatment for Hip Periprosthetic Infection. , 2017, The Journal of arthroplasty.

[36]  P. Wischmeyer,et al.  Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis , 2016, Critical Care.

[37]  P. Wilmes,et al.  The human gut microbiome in health: establishment and resilience of microbiota over a lifetime , 2016, Environmental microbiology.

[38]  Atsushi Mizoguchi,et al.  Current Understanding of Dysbiosis in Disease in Human and Animal Models , 2016, Inflammatory bowel diseases.

[39]  M. Whitehouse,et al.  Patient-Related Risk Factors for Periprosthetic Joint Infection after Total Joint Arthroplasty: A Systematic Review and Meta-Analysis , 2016, PloS one.

[40]  R. Talukdar,et al.  Role of the normal gut microbiota. , 2015, World journal of gastroenterology.

[41]  Michael M. Lederman,et al.  Soluble CD14 is a nonspecific marker of monocyte activation , 2015, AIDS.

[42]  Bernard M. Corfe,et al.  Dysbiosis of the gut microbiota in disease , 2015, Microbial ecology in health and disease.

[43]  H. El-Gabalawy,et al.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE , 2014, Nature Reviews Rheumatology.

[44]  M. Rovers,et al.  SYRCLE’s risk of bias tool for animal studies , 2014, BMC Medical Research Methodology.

[45]  J. Parvizi,et al.  Proceedings of the International Consensus on Periprosthetic Joint Infection. , 2013, The bone & joint journal.

[46]  E. Dempsey,et al.  Microbial Composition of Human Appendices from Patients following Appendectomy , 2013, mBio.

[47]  Heather N. Watson,et al.  Economic burden of periprosthetic joint infection in the United States. , 2012, The Journal of arthroplasty.

[48]  L. Vannucci,et al.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases , 2011, Cellular and Molecular Immunology.

[49]  G. Sabbioni,et al.  Two Stage Hip Revision in Periprosthetic Infection: Results of 41 Cases , 2010, The open orthopaedics journal.

[50]  L. Havelin,et al.  Knee arthroplasty in Denmark, Norway and Sweden , 2010, Acta orthopaedica.

[51]  S. Kurtz,et al.  Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. , 2009, The Journal of arthroplasty.

[52]  S. Kurtz,et al.  Infection burden for hip and knee arthroplasty in the United States. , 2008, The Journal of arthroplasty.

[53]  R. Sartor,et al.  Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. , 2017, Gastroenterology.

[54]  A. Hanssen,et al.  Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.